COMMUNIQUÉS West-GlobeNewswire

Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership

18/07/2018 - 14:00

RENSSELAER, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated services, announced a [...]

FDA Accepts Biologics License Application for Filing and Grants Priority Review for Sacituzumab Govitecan for the Treatment of Metastatic Triple-negative Breast Cancer

18/07/2018 - 14:00

The Prescription Drug User Fee Act (PDUFA) Target Action Date is January 18, 2019 MORRIS PLAINS, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leading [...]

Pediapharm Announces Annual Audited Financial Results – 61% Annual Revenue Growth and 11th Consecutive Year-over-year Quarterly Growth

18/07/2018 - 14:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, July 18, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the “Company” or "Pediapharm") (TSX VENTURE:PDP) (OTCQB:PDDPF) is [...]

Pediapharm annonce ses résultats financiers audités annuels - hausse annuelle de 61% des revenus et 11e trimestre consécutif de croissance d’un exercice à l’autre

18/07/2018 - 14:00

N’EST PAS DESTINÉ À LA DISTRIBUTION AUX AGENCES DE PRESSE AMÉRICAINES NI À LA DIFFUSION AUX ÉTATS-UNIS MONTRÉAL, 18 juill. 2018 (GLOBE NEWSWIRE) -- Pediapharm inc. (la « Société » ou « Pediapharm ») (TSX CROISSANCE:PDP [...]

Inovalon Announces Second Quarter 2018 Earnings Conference Call

18/07/2018 - 13:55

BOWIE, Md., July 18, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that it will hold a [...]

Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results

18/07/2018 - 13:37

Third consecutive quarter of triple-digit YoY Quarterly growth NEW HAVEN, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced preliminary second [...]

Takeda and Ovid Therapeutics Expand Clinical Program for TAK-935/OV935 with Three New Studies in Rare Developmental and Epileptic Encephalopathies (DEE)

18/07/2018 - 13:30

Broad clinical program to include three studies expected to begin in the third quarter of calendar year 2018 in addition to the now fully enrolled Phase 1b/2a trial of adults with DEE Two rare disorders, CDKL5 [...]

Eloxx Pharmaceuticals To Present at the 38th Annual Canaccord Genuity Growth Conference

18/07/2018 - 13:30

WALTHAM, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]

Moleculin Expects to Meet FDA IND Filing Requirements for its Pancreatic Cancer Drug Candidate with Development Work in Australia

18/07/2018 - 13:30

HOUSTON, July 18, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Data to be Presented From Biogen’s Alzheimer’s Disease Clinical Development Portfolio at the 2018 Alzheimer’s Association International Conference (AAIC)

18/07/2018 - 13:30

Ongoing Alzheimer’s disease research programs target possible causes of the disease through multiple modalities Data to be presented from Alzheimer’s disease clinical development portfolio including aducanumab, [...]

Avalon GloboCare Announces Plans to Accelerate Commercialization of Proprietary CAR-T Technologies through Launch of Wholly Owned Subsidiary - Avactis Biosciences

18/07/2018 - 13:30

FREEHOLD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that the Company has formed a new wholly [...]

Adaptimmune Announces Favorable Review of Safety from One Billion Cell Dose Cohort in MAGE-A10 SPEAR T-cell Study and Initiation of Third Dosing Cohorts

18/07/2018 - 13:29

PHILADELPHIA and OXFORD, United Kingdom, July 18, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced favorable review of safety data from the [...]

Myriad Announces Coverage Decision by Kroger® Prescription Plans for Vectra DA®

18/07/2018 - 13:05

SALT LAKE CITY, July 18, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced that Kroger Prescription Plans, will provide Vectra ® DA as a benefit [...]

Akers Biosciences Signs a Further Independent Sales Representative Organization for Heparin PF4 Rapid Test Covering Additional 12 States

18/07/2018 - 13:01

THOROFARE, N.J.,, July 18, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces another agreement [...]

Evogene Financial Results for the Second Quarter of 2018

18/07/2018 - 13:00

Earnings Announcement Schedule REHOVOT, Israel, July 18, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets, announced [...]

Catalyst Biosciences Announces Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors

18/07/2018 - 13:00

Interim data support goal of significantly reducing annualized bleed rates with daily subcutaneous injections of marzeptacog alfa (activated) Conference call and webcast to be held today, July 18, 2018 at 8:30 a.m. EDT [...]

Emblem Announces $3 Million Strategic Equity Investment in Natura Naturals and 9,000 kg Supply Agreement over three years

18/07/2018 - 12:30

TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (OTCBB:EMMBF) (“Emblem” or the “Company”), announced today that it is making a strategic equity investment (the “Equity Investment”) into [...]

Orion Group Half-Year Financial Report January-June 2018

18/07/2018 - 11:01

ORION CORPORATION HALF-YEAR FINANCIAL REPORT JANUARY-JUNE 2018 18 JULY 2018 at 12:00 EEST Orion Group Half-Year Financial Report January-June 2018 Orion's net sales for continuing operations in January-June 2018 [...]

Orion Corporation's financial reporting and Annual General Meeting in 2019

18/07/2018 - 10:01

ORION CORPORATION STOCK EXCHANGE RELEASE 18 JULY 2018 at 11.00 EEST Orion Corporation's financial reporting and Annual General Meeting in 2019 Orion Corporation will publish its Financial Statement Release 2018 on [...]